Maini, R., Taylor, P., Paleolog, E., Charles, P., Ballara, S., Brennan, F., & Feldmann, M. (1999). Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
Style de citation ChicagoMaini, R., P. Taylor, E. Paleolog, P. Charles, S. Ballara, F. Brennan, et M. Feldmann. Anti-tumour Necrosis Factor Specific Antibody (infliximab) Treatment Provides Insights Into the Pathophysiology of Rheumatoid Arthritis. 1999.
Style de citation MLAMaini, R., et al. Anti-tumour Necrosis Factor Specific Antibody (infliximab) Treatment Provides Insights Into the Pathophysiology of Rheumatoid Arthritis. 1999.
Attention : ces citations peuvent ne pas être correctes à 100%.